- Supported exchanges /
- NASDAQ /
- DWTX.NASDAQ
Dogwood Therapeutics, Inc. (DWTX NASDAQ) stock market data APIs
Dogwood Therapeutics, Inc., a development-stage biotechnology company, focuses on developing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response. The company's lead development candidate is the IMC-1, a fixed dose combination of famciclovir and celecoxib to treat fibromyalgia. It also develops IMC-2, a combination of valacyclovir and celecoxib for the treatment of managing the fatigue, sleep, attention, pain, autonomic function, and anxiety associated with long COVID. The company was formerly known as Virios Therapeutics, Inc. and changed its name to Dogwood Therapeutics, Inc. in October 2024. The company was founded in 2012 and is headquartered in Alpharetta, Georgia.
Dogwood Therapeutics, Inc. Financial Data Overview
| 2.87 | |
| 2.6 | |
| - | |
| 2.88 | |
| 2.5 | |
| 1.62-23.5 | |
| 0 | |
| 0 | |
| 0 | |
| -1.1461 | |
No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.
Dogwood Therapeutics, Inc. Fundamental Data is available in our Financial Data APIs
- Net Revenue 0
- EBITDA 0
- Earnings Per Share
- Income Statements
- Balance Sheets
- Cash flows
of Fundamental API Data
Get Dogwood Therapeutics, Inc. Earnings via APIs
- Latest Release 2024-08-08
- EPS/Forecast NaN
Get Dogwood Therapeutics, Inc. End-of-day Data via APIs
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Our 24/7 support would be happy to assist you via chat or email:
support@eodhistoricaldata.comVisit also:
